https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18380 Sat 24 Mar 2018 07:52:42 AEDT ]]> Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18511 Sat 24 Mar 2018 07:50:08 AEDT ]]> A randomised trial investigating the effect on biochemical (PSA) control and survival of different durations of adjuvant androgen deprivation in association with definitive radiation treatment for localised carcinoma of the prostate https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33247 7 cutpoint identified in 2014 for the BP and STI endpoints. A tertiary objective of the trial is to determine whether intercurrent medical conditions will impact independently on delayed radiotherapy morbidity and other treatment related morbidity.]]> Mon 23 Sep 2019 13:37:53 AEST ]]>